institution
Eliada Homes, Inc.
Mental Illness Community Based Residential Treatment Facility in Asheville, North Carolina
NPI 1679088389

Eliada Homes, Inc. is a Mental Illness Community Based Residential Treatment Facility based in Asheville, NC. Eliada Homes, Inc. practices in Asheville, NC. The NPI Number for Eliada Homes, Inc. is 1679088389 and holds a License No. (North Carolina).

The current practice location address for Eliada Homes, Inc. is 2 Compton Dr, Asheville, NC and can be reached out via phone at 828-254-5356 and via fax at 828-210-0231. You can also correspond with Eliada Homes, Inc. through the mailing address at PO BOX 16708, ASHEVILLE, NC - 28816-0708 (mailing address contact number: 828-254-5356).

Location: 2 Compton Dr, Asheville, NC, 28816-0708
institution
Provider Profile Details
NPI Number
1679088389
Provider Name
Eliada Homes, Inc.
Credential
Provider Entity Type
Organization
Address
2 Compton Dr, Asheville, NC, 28816-0708
Phone Number
828-254-5356
Fax Number
828-210-0231
Provider Enumeration Date
12/05/2017
Last Update Date
03/10/2024
institution
Provider Business Practice Location Address Details
Address
2 Compton Dr
City
State
Zip
28806-2054
Phone Number
828-254-5356
Fax Number
828-210-0231
person
Provider Business Mailing Address Details
Address
2 Compton Dr
City
State
Zip
28806-2054
Phone Number
828-254-5356
Fax Number
828-210-0231
person
Provider's Taxonomy Details 1
Type
Residential Treatment Facilities
Classification
Community Based Residential Treatment Facility, Mental Illness
Speciality
-
Taxonomy
License No.
()
Definition
A home-like residential facility providing psychiatric treatment and psycho/social rehabilitative services to individuals diagnosed with mental illness.
semi-verified symbol
Badge

Use the following badge on your website to showcase your NPI number and verified status. In a field with over 8 million healthcare providers in the United States, it is important to establish your identity clearly. Displaying this badge signifies that your information is both accurate and up-to-date.